Quality Assessment of Clinical Ethics Consultation. Reflection on the Applicability of the Ethics Consultation Quality Assessment Tool

2021 ◽  
Vol 66 (Special Issue) ◽  
pp. 134-134
Author(s):  
Stephan Nadolny ◽  
◽  
Andre Nowak ◽  
Nicolas Heirich ◽  
Jan Schildmann ◽  
...  
Keyword(s):  
Quality Assessment ◽  
Clinical Ethics ◽  
Assessment Tool ◽  
Ethics Consultation ◽  
Process Quality ◽  
Ethical Analysis ◽  
Clinical Ethics Consultation ◽  
Quality Assessment Tool ◽  
Essential Components

"Background. Clinical ethics consultation has been implemented in many health care institutions. Different methods exist for their evaluation. In this paper we present findings from an evaluation of 21 documentation conducted 2019-2020 by means of the Ethics Consultation Quality Assessment Tool (ECQAT). The applicability of the instrument was analyzed based on a) duration of use, b) ease of use, c) comprehensibility of the items. Results. On average, the analysis with the ECQAT takes 11 minutes per protocol. The greatest difficulties in applying the ECQAT arise a) in assessing the counselling-related information and b) in assessing the ethical analysis as well as the recommendations. Here, different demands on the level of detail of the information may lead to different assessments. Furthermore, the transitions of the ethical analysis and the recommendations, which are relevant for the assessment, could not be delimited exactly in parts of the protocols. Discussion. The assessment of documentation represents a limited part of the quality of ethics consultation. In particular, the quality dimensions of the EQAT do not map communicative elements of process quality, which are essential components (if not the core) of ethics consultations. Moreover, the assessment is strongly depending on the format of the protocols, which, depending on the institution, range from a brief overview of the results to a detailed account. Even in light of aforementioned limitations the ECQAT provides an incentive to improve the process quality of (documented) ethics consultation. "

Ethics Consultation Quality Assessment Tool: A Novel Method for Assessing the Quality of Ethics Case Consultations Based on Written Records

2016 ◽  
Vol 16 (3) ◽  
pp. 3-14 ◽  
Author(s):  
Robert A. Pearlman ◽  
Mary Beth Foglia ◽  
Ellen Fox ◽  
Jennifer H. Cohen ◽  
Barbara L. Chanko ◽  
...  
Keyword(s):  
Quality Assessment ◽  
Assessment Tool ◽  
Ethics Consultation ◽  
Quality Assessment Tool ◽  
Novel Method

scholarly journals Institute of Medical Ethics Guidelines for confirmation of appointment, promotion and recognition of UK bioethics and medical ethics researchers

2018 ◽  
Vol 44 (5) ◽  
pp. 289-291
Author(s):  
Lucy Frith ◽  
Carwyn Hooper ◽  
Silvia Camporesi ◽  
Thomas Douglas ◽  
Anna Smajdor ◽  
...  
Keyword(s):  
Medical Ethics ◽  
Detailed Analysis ◽  
Clinical Ethics ◽  
Peer Assessment ◽  
Ethics Consultation ◽  
Clinical Ethics Consultation ◽  
Policy Work ◽  
Disciplinary Background ◽  
Ethics Guidelines

This document is designed to give guidance on assessing researchers in bioethics/medical ethics. It is intended to assist members of selection, confirmation and promotion committees, who are required to assess those conducting bioethics research when they are not from a similar disciplinary background. It does not attempt to give guidance on the quality of bioethics research, as this is a matter for peer assessment. Rather it aims to give an indication of the type, scope and amount of research that is the expected in this field. It does not cover the assessment of other activities such as teaching, policy work, clinical ethics consultation and so on, but these will be mentioned for additional context. Although it mentions the UK’s Research Excellence Framework (REF), it is not intended to be a detailed analysis of the place of bioethics in the REF.

scholarly journals The association between self-efficacy and self-care in essential hypertension: a systematic review

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Felicia Clara Jun Hui Tan ◽  
Prawira Oka ◽  
Hajira Dambha-Miller ◽  
Ngiap Chuan Tan
Keyword(s):  
Systematic Review ◽  
Quality Assessment ◽  
Self Efficacy ◽  
Observational Studies ◽  
Cognitive Theory ◽  
Assessment Tool ◽  
Self Care ◽  
Quality Assessment Tool ◽  
Medium Quality

Abstract Background The successful management of hypertension requires sustained engagement in self-care behaviour such as adhering to medication regimens and diet. Bandura’s Social Cognitive Theory suggests that self-efficacy is a major determinant of engagement in self-care behaviour. Self-efficacy refers to an individual’s belief in their capacity to execute behaviours necessary to produce specific performance attainments. This systematic review of observational studies aims to summarise and evaluate the quality of evidence available to support the association between self-efficacy and engagement in self-care behaviour in hypertension. Methods Searches were performed of the Pubmed, MEDLINE, CINAHL and OpenSIGLE databases from database inception to January 2020. Reference lists and individual journals were also hand searched. Observational studies in English quantifying self-efficacy and self-care behaviour in hypertensive adults were included. The quality of included articles was assessed with the National Institute of Health Quality Assessment Tool for observational studies. Results The literature search identified 102 studies, of which 22 met the inclusion criteria for full-text review. There were 21 studies which reported that higher self-efficacy was associated with engagement in self-care behaviours including medication adherence (n = 9), physical activity (n = 2) and dietary changes (n = 1). Of these, 12 studies were rated as ‘good’ on the quality assessment tool and 10 were ‘fair’. A common limitation in these studies was a lack of objectivity due to their reliance on self-reporting of engagement in self-care behaviour. Conclusion Our review suggests an association between self-efficacy and self-care. However, the evidence supporting this association is of low to medium quality and is limited by heterogeneity. Our findings suggest the need for further well-designed interventional studies to investigate this association.

scholarly journals Usability as a Premise of Quality

2019 ◽  
Vol 2 (2) ◽  
pp. 57-71
Author(s):  
Irene Tor-Carroggio ◽  
Daniel Segura ◽  
Olga Soler-Vilageliu
Keyword(s):  
Quality Assessment ◽  
Assessment Tool ◽  
Future Research ◽  
Quality Assessment Tool ◽  
Testing Phase ◽  
European Project ◽  
System Usability Scale ◽  
System Usability ◽  
Key Factor

Usability is a key factor when talking about the quality of a product. The System Usability Scale (SUS) is one of the most popular tools to measure usability due to its numerous advantages and, therefore, a very useful quality assessment tool. Originally designed in English, it is available in some other languages, such as Persian and Greek but no validated version in Spanish can be found yet. This paper bridges this gap by describing the process of statistically validating the SUS into Spanish. The results show that our translation of the SUS is reliable, although our modest sample of informants (N = 50) leaves room for improvement and future research. The validation of the SUS is framed within a European project that will use it for its testing phase.

scholarly journals The Bellerophon pipeline, improving de novo transcriptomes and removing chimeras

2018 ◽  
Author(s):  
Jesse Kerkvliet ◽  
Arthur de Fouchier ◽  
Michiel van Wijk ◽  
Astrid T. Groot
Keyword(s):  
Quality Control ◽  
Quality Assessment ◽  
Reference Genome ◽  
Assessment Tool ◽  
De Novo ◽  
Transcriptome Assembly ◽  
Rna Seq ◽  
Quality Assessment Tool ◽  
Chimeric Sequences

AbstractTranscriptome quality control is an important step in RNA-seq experiments. However, the quality of de novo assembled transcriptomes is difficult to assess, due to the lack of reference genome to compare the assembly to. We developed a method to assess and improve the quality of de novo assembled transcriptomes by focusing on the removal of chimeric sequences. These chimeric sequences can be the result of faulty assembled contigs, merging two transcripts into one. The developed method is incorporated into a pipeline, that we named Bellerophon, which is broadly applicable and easy to use. Bellerophon first uses the quality-assessment tool TransRate to indicate the quality, after which it uses a Transcripts Per Million (TPM) filter to remove lowly expressed contigs and CD-HIT-EST to remove highly identical contigs. To validate the quality of this method, we performed three benchmark experiments: 1) a computational creation of chimeras, 2) identification of chimeric contigs in a transcriptome assembly, 3) a simulated RNAseq experiment using a known reference transcriptome. Overall, the Bellerophon pipeline was able to remove between 40 to 91.9% of the chimeras in transcriptome assemblies and removed more chimeric than non-chimeric contigs. Thus, the Bellerophon sequence of filtration steps is a broadly applicable solution to improve transcriptome assemblies.

scholarly journals Introducing clinical ethics consultation service in Malaysia: A SWOT analysis

2019 ◽  
Vol 14 (1) ◽  
pp. 26-32 ◽  
Author(s):  
Erwin Jiayuan Khoo ◽  
Siew Houy Chua ◽  
Meow-Keong Thong ◽  
Bin Alwi Zilfalil ◽  
John Lantos
Keyword(s):  
Clinical Ethics ◽  
Swot Analysis ◽  
Critical Mass ◽  
National Level ◽  
Ethics Consultation ◽  
Clinical Ethics Consultation ◽  
Cultural Barriers ◽  
Consultation Service ◽  
Insight Into

Clinical ethics consultation service remains undeveloped in developing countries. It is recognised that its introduction poses challenges. Malaysia, a multicultural society with diverse religions, values and perceptions further complicate the introduction of formal clinical ethics consultation service. Clinicians attending a national congress workshop completed a Strengths–Weaknesses–Opportunities–Threats analysis. The aim was to gain insight into clinician’s expectations and promote initiatives leading to the introduction of clinical ethics consultation service. Clinicians agree that clinical ethics consultation service can improve quality of care, reduce healthcare costs and advocate for patients and providers. The analysis highlighted constraints in sufficient critical mass of relevant expertise and restricted opportunities for training. The opportunities lie in education, curriculum development and availability of dedicated proponents. Cultural barriers, limited resources, lack of awareness, differences in opinions, fear of litigation and destructive influence of social media are seen as threats to the introduction of clinical ethics consultation service. This study illustrates the value of involving stakeholders when introducing clinical ethics consultation service formally. The issues identified will inform the strategic directions for the delivery of clinical ethics consultation service at a national level.

Sign in / Sign up

Export Citation Format

Share Document